BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10830531)

  • 1. Biodistribution and breast tumor uptake of 16alpha-[18F]-fluoro-17beta-estradiol in rat.
    Sasaki M; Fukumura T; Kuwabara Y; Yoshida T; Nakagawa M; Ichiya Y; Masuda K
    Ann Nucl Med; 2000 Apr; 14(2):127-30. PubMed ID: 10830531
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Xu D; Zhuang R; You L; Guo Z; Wang X; Peng C; Zhang D; Zhang P; Wu H; Pan W; Zhang X
    Nucl Med Biol; 2018 Apr; 59():48-55. PubMed ID: 29466767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of 7α-(3-[(18)F]fluoropropyl) estradiol.
    Okamoto M; Naka K; Kitagawa Y; Ishiwata K; Yoshimoto M; Shimizu I; Toyohara J
    Nucl Med Biol; 2015 Jul; 42(7):590-7. PubMed ID: 25823392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [18F]-fluoroestradiol quantitative PET imaging to differentiate ER+ and ERα-knockdown breast tumors in mice.
    Paquette M; Ouellet R; Archambault M; Croteau É; Lecomte R; Bénard F
    Nucl Med Biol; 2012 Jan; 39(1):57-64. PubMed ID: 22079037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 16 beta-([18F]fluoro)estrogens: systematic investigation of a new series of fluorine-18-labeled estrogens as potential imaging agents for estrogen-receptor-positive breast tumors.
    VanBrocklin HF; Carlson KE; Katzenellenbogen JA; Welch MJ
    J Med Chem; 1993 May; 36(11):1619-29. PubMed ID: 7684451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the uptake of 16 alpha-([18F]fluoro)-17 beta-estradiol in DMBA-induced mammary tumors.
    Mathias CJ; Welch MJ; Katzenellenbogen JA; Brodack JW; Kilbourn MR; Carlson KE; Kiesewetter DO
    Int J Rad Appl Instrum B; 1987; 14(1):15-25. PubMed ID: 3108199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [18F]Fluorinated estradiol derivatives for oestrogen receptor imaging: impact of substituents, formulation and specific activity on the biodistribution in breast tumour-bearing mice.
    Bénard F; Ahmed N; Beauregard JM; Rousseau J; Aliaga A; Dubuc C; Croteau E; van Lier JE
    Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1473-9. PubMed ID: 18360749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-labeled difluoroestradiols: preparation and preclinical evaluation as estrogen receptor-binding radiopharmaceuticals.
    Seimbille Y; Rousseau J; Bénard F; Morin C; Ali H; Avvakumov G; Hammond GL; van Lier JE
    Steroids; 2002 Aug; 67(9):765-75. PubMed ID: 12123788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of an estrogen receptor beta-selective radioligand: 5-[18F]fluoro-(2R,3S)-2,3-bis(4-hydroxyphenyl)pentanenitrile and comparison of in vivo distribution with 16alpha-[18F]fluoro-17beta-estradiol.
    Yoo J; Dence CS; Sharp TL; Katzenellenbogen JA; Welch MJ
    J Med Chem; 2005 Oct; 48(20):6366-78. PubMed ID: 16190762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Titration of the in vivo uptake of 16 alpha-[18F]fluoroestradiol by target tissues in the rat: competition by tamoxifen, and implications for quantitating estrogen receptors in vivo and the use of animal models in receptor-binding radiopharmaceutical development.
    Katzenellenbogen JA; Mathias CJ; VanBrocklin HF; Brodack JW; Welch MJ
    Nucl Med Biol; 1993 Aug; 20(6):735-45. PubMed ID: 8401374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy.
    Mortimer JE; Dehdashti F; Siegel BA; Katzenellenbogen JA; Fracasso P; Welch MJ
    Clin Cancer Res; 1996 Jun; 2(6):933-9. PubMed ID: 9816253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo imaging of brain estrogen receptors in rats: a 16α-18F-fluoro-17β-estradiol PET study.
    Khayum MA; de Vries EF; Glaudemans AW; Dierckx RA; Doorduin J
    J Nucl Med; 2014 Mar; 55(3):481-7. PubMed ID: 24481026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the novel estrogen receptor PET tracer 4-fluoro-11β-methoxy-16α-[(18)F]fluoroestradiol (4FMFES) by PET imaging in a breast cancer murine model.
    Paquette M; Phoenix S; Ouellet R; Langlois R; van Lier JE; Turcotte EE; Bénard F; Lecomte R
    Mol Imaging Biol; 2013 Oct; 15(5):625-32. PubMed ID: 23619898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact on estrogen receptor binding and target tissue uptake of [18F]fluorine substitution at the 16alpha-position of fulvestrant (faslodex; ICI 182,780).
    Seimbille Y; Bénard F; Rousseau J; Pepin E; Aliaga A; Tessier G; van Lier JE
    Nucl Med Biol; 2004 Aug; 31(6):691-8. PubMed ID: 15246359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current applications of PET imaging of sex hormone receptors with a fluorinated analogue of estradiol or of testosterone.
    Talbot JN; Gligorov J; Nataf V; Montravers F; Huchet V; Michaud L; Ohnona J; Balogova S; Cussenot O; Daraï E; Lotz JP; Kerrou K
    Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):4-17. PubMed ID: 25693420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative breast tumor imaging and comparative in vitro metabolism of 16alpha-[18F]fluoroestradiol-17beta and 16beta-[18F]fluoromoxestrol in isolated hepatocytes.
    Jonson SD; Bonasera TA; Dehdashti F; Cristel ME; Katzenellenbogen JA; Welch MJ
    Nucl Med Biol; 1999 Jan; 26(1):123-30. PubMed ID: 10096512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer models to study the expression of estrogen receptors with small animal PET imaging.
    Aliaga A; Rousseau JA; Ouellette R; Cadorette J; van Lier JE; Lecomte R; Bénard F
    Nucl Med Biol; 2004 Aug; 31(6):761-70. PubMed ID: 15246367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 16 alpha-[77Br]bromoestradiol-17 beta: a high specific-activity, gamma-emitting tracer with uptake in rat uterus and uterus and induced mammary tumors.
    Katzenellenbogen JA; Senderoff SG; McElvany KD; O'Brien HA; Welch MJ
    J Nucl Med; 1981 Jan; 22(1):42-7. PubMed ID: 6778976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions using
    Jager A; de Vries EGE; der Houven van Oordt CWM; Neven P; Venema CM; Glaudemans AWJM; Wang Y; Bagley RG; Conlan MG; Aftimos P
    Breast Cancer Res; 2020 Sep; 22(1):97. PubMed ID: 32912274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor-binding radiopharmaceuticals for imaging breast tumors: estrogen-receptor interactions and selectivity of tissue uptake of halogenated estrogen analogs.
    Katzenellenbogen JA; Carlson KE; Heiman DF; Goswami R
    J Nucl Med; 1980 Jun; 21(6):550-8. PubMed ID: 6247466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.